Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers.
D000328:Adult; D000583:Amikacin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D005260:Female; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007612:Kanamycin / Q000031:analogs & derivatives*; D007700:Kinetics; D008297:Male; D013997:Time Factors
D007612:Kanamycin; D000583:Amikacin